CIK 0001574094
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271448452
- Phone
- +1 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $46,485
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$46,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-03 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +128,550 | 128,550 | ||
| 2025-07-01 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +6,619 | 6,619 | ||
| 2025-04-14 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +26,477 | 26,477 | ||
| 2024-03-06 | Gentry Leesa Chief Clinical Officer | Grant or award · Options | +190,000 | 190,000 |
Page 1 of 1 · 4 trades